38801405|t|Lithium prevents glucocorticoid-induced osteonecrosis of the femoral head by regulating autophagy.
38801405|a|Autophagy may play an important role in the occurrence and development of glucocorticoid-induced osteonecrosis of the femoral head (GC-ONFH). Lithium is a classical autophagy regulator, and lithium can also activate osteogenic pathways, making it a highly promising therapeutic agent for GC-ONFH. We aimed to evaluate the potential therapeutic effect of lithium on GC-ONFH. For in vitro experiments, primary osteoblasts of rats were used for investigating the underlying mechanism of lithium's protective effect on GC-induced autophagy levels and osteogenic activity dysfunction. For in vivo experiments, a rat model of GC-ONFH was used for evaluating the therapeutic effect of oral lithium on GC-ONFH and underlying mechanism. Findings demonstrated that GC over-activated the autophagy of osteoblasts and reduced their osteogenic activity. Lithium reduced the over-activated autophagy of GC-treated osteoblasts through PI3K/AKT/mTOR signalling pathway and increased their osteogenic activity. Oral lithium reduced the osteonecrosis rates in a rat model of GC-ONFH, and restrained the increased expression of autophagy related proteins in bone tissues through PI3K/AKT/mTOR signalling pathway. In conclusion, lithium can restrain over-activated autophagy by activating PI3K/AKT/mTOR signalling pathway and up-regulate the expression of genes for bone formation both in GC induced osteoblasts and in a rat model of GC-ONFH. Lithium may be a promising therapeutic agent for GC-ONFH. However, the role of autophagy in the pathogenesis of GC-ONFH remains controversial. Studies are still needed to further explore the role of autophagy in the pathogenesis of GC-ONFH, and the efficacy of lithium in the treatment of GC-ONFH and its underlying mechanisms.
38801405	0	7	Lithium	Chemical	MESH:D008094
38801405	40	73	osteonecrosis of the femoral head	Disease	MESH:D000070603
38801405	196	229	osteonecrosis of the femoral head	Disease	MESH:D000070603
38801405	231	238	GC-ONFH	Disease	
38801405	241	248	Lithium	Chemical	MESH:D008094
38801405	289	296	lithium	Chemical	MESH:D008094
38801405	387	394	GC-ONFH	Disease	
38801405	453	460	lithium	Chemical	MESH:D008094
38801405	464	471	GC-ONFH	Disease	
38801405	522	526	rats	Species	10116
38801405	583	590	lithium	Chemical	MESH:D008094
38801405	614	616	GC	Disease	
38801405	706	709	rat	Species	10116
38801405	719	726	GC-ONFH	Disease	
38801405	782	789	lithium	Chemical	MESH:D008094
38801405	793	800	GC-ONFH	Disease	
38801405	940	947	Lithium	Chemical	MESH:D008094
38801405	988	990	GC	Chemical	MESH:C057580
38801405	1019	1023	PI3K	Gene	85243
38801405	1024	1027	AKT	Gene	24185
38801405	1028	1032	mTOR	Gene	56718
38801405	1098	1105	lithium	Chemical	MESH:D008094
38801405	1118	1131	osteonecrosis	Disease	MESH:D010020
38801405	1143	1146	rat	Species	10116
38801405	1156	1163	GC-ONFH	Disease	
38801405	1259	1263	PI3K	Gene	85243
38801405	1264	1267	AKT	Gene	24185
38801405	1268	1272	mTOR	Gene	56718
38801405	1308	1315	lithium	Chemical	MESH:D008094
38801405	1368	1372	PI3K	Gene	85243
38801405	1373	1376	AKT	Gene	24185
38801405	1377	1381	mTOR	Gene	56718
38801405	1468	1470	GC	Disease	
38801405	1500	1503	rat	Species	10116
38801405	1513	1520	GC-ONFH	Disease	
38801405	1522	1529	Lithium	Chemical	MESH:D008094
38801405	1571	1578	GC-ONFH	Disease	
38801405	1634	1641	GC-ONFH	Disease	
38801405	1754	1761	GC-ONFH	Disease	
38801405	1783	1790	lithium	Chemical	MESH:D008094
38801405	1811	1818	GC-ONFH	Disease	
38801405	Association	MESH:D008094	24185
38801405	Negative_Correlation	MESH:D008094	MESH:D000070603
38801405	Negative_Correlation	MESH:D008094	MESH:D010020
38801405	Positive_Correlation	MESH:D008094	85243
38801405	Association	MESH:D008094	56718

